BHSAI News Archive 2017

Prescription drugs and medications are safe when we take them as directed. However, once we start taking more than one type of drug, our risk of experiencing adverse health reactions due to the combination increases. Although we now have over 1,000 drugs approved by the Food and Drug Administration (FDA), most drug combinations are never evaluated for safety. If certain drug combinations have the capacity to affect our health, we need to be able to flag them.

This year, two of TATRC Labs joined forces and teamed together. TATRC’s Operational Telemedicine (Op-T-med) Lab and the Biotechnology High Performance Computing Software Applications Institute (BHSAI), began a collaborative effort to implement BHSAI’s Automated Processing of the Physiologic Registry for Assessment of Injury Severity (APPRAISE) system on a mobile device.

On 18 May, top researchers & scientists from all branches of DoD, gathered for an interactive exhibition in the central courtyard at the Pentagon in Arlington, Virginia.

The upsurge in terrorism attacks makes the development of effective countermeasures all the more imperative. Biological pathogens can potentially be employed in a terrorism incident and pose substantial risks to Force Health Protection as well as to the public.

Warfighters are increasingly at risk from environmental health hazards during deployment, where exposure to an accidental or intentional release of chemical toxicants can cause both acute and long-term health problems.